199287-52-0

Usage

Uses

Used in Pharmaceutical Industry:
Benzaldehyde, 4,5-difluoro-2-hydroxy(9CI) is used as an intermediate in the synthesis of pharmaceutical compounds due to its unique structure and reactivity. Its presence in the molecule can enhance the biological activity and selectivity of the resulting drug candidates, making it a valuable component in the development of new medications.
Used in Agrochemical Industry:
In the agrochemical industry, Benzaldehyde, 4,5-difluoro-2-hydroxy(9CI) can be utilized as a building block for the creation of novel agrochemicals with improved efficacy and selectivity. Its unique chemical properties may contribute to the development of more effective and environmentally friendly pesticides, herbicides, or other agricultural chemicals.
Used in Materials Science:
Benzaldehyde, 4,5-difluoro-2-hydroxy(9CI) may also find applications in materials science, where its unique structure can be leveraged to develop new materials with specific properties. For instance, it could be used in the synthesis of polymers, coatings, or other materials with enhanced performance characteristics, such as improved thermal stability, chemical resistance, or other desirable traits.
Further research and testing are necessary to fully understand the potential uses and properties of Benzaldehyde, 4,5-difluoro-2-hydroxy(9CI), as its unique structure and reactivity may unlock new opportunities across various industries.

InChI:InChI=1/C7H4F2O2/c8-5-1-4(3-10)7(11)2-6(5)9/h1-3,11H

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 166281-37-4 2-bromo-4,5-difluorophenol 
• 145742-34-3 4,5-difluoro-2-methoxybenzaldehyde 

Relevant academic research and scientific papers

BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF P13K- a AND/OR B

Compounds with unique liphagane meroterpenoid scaffold having boronic acid functionality in the skeleton are described (formula 1) together with pharmacological potential of these compounds as anticancer agents. A method of preparation and inhibiting the activity of phosphoinositide-3-kinase (PI3K-alpha and beta) has been presented. In particular, the invention describes a method of inhibiting PI3K isoforms, wherein the compounds are novel structures based on liphagane scaffold with unique boronic acid functionality. The methods and uses thereof are described herein this invention.

BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF PI3K-alpha AND/OR beta

Compounds with unique liphagane meroterpenoid scaffold having boronic acid functionality in the skeleton are described [formula 1] together with pharmacological potential of these compounds as anticancer agents. A method of preparation and inhibiting the activity of phosphoinositide-3-kinase (PI3K-alpha and beta) has been presented. In particular, the invention describes a method of inhibiting PI3K isoforms, wherein the compounds are novel structures based on liphagane scaffold with unique boronic acid functionality. The methods and uses thereof are described herein this invention. The claimed Markush formula is: [Formular 1], Y can be O, NH, NR, S; Representative compounds are: [Compounds A, B, C, D]

HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS

Compounds of formula (I) and pharmaceutically acceptable salts thereof are agonists at the beta-2 adrenoceptor. They are useful as feed additives for livestock animals.

BENZOFURYL DERIVATIVES AND THEIR USE

The invention is concerned with the use of compounds of general formula (I) wherein R1-R4signify hydrogen, halogen, lower-alkyl, lower-alkoxy, aryl, benzyloxy, lower-alkoxy-lower-alkyl, lower-alkyl-sulphanyl, lower-alkyl-sulphanyl-lower-alkyl or R1and R2t

METHOD OF TREATING DISEASES OF THE CNS

The invention is concerned with the use of compounds of the general formula STR1 wherein R 1-R 4 signify hydrogen, halogen, lower-alkyl, lower-alkoxy, aryl, benzyloxy, lower-alkoxy-lower-alkyl, lower-alkyl-sulphanyl, lower-alkyl-sulphanyl-lower-alkyl or R